The Department of Endocrinology, 
Physio-Friendly Remission-Facilitating Pharmacotherapy (PRP) in Type 2 Diabetes.
- Department of Endocrinology, Bharti Hospital, Karnal, India
- University Center for Research & Development, Chandigarh University, Mohali, India.
- Department of Medicine, Alchemist Hospital, Panchkula, India.
- Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India
- Non-communicable disease unit, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
JPMA. The Journal of the Pakistan Medical Association Vol. 74 · Issue 11 · pp. 2012-2013
PMID 39548626 DOI 10.47391/jpma.24-89
Cite This Article
Sanjay Kalra, Suneet Verma, Nitin Kapoor. Physio-Friendly Remission-Facilitating Pharmacotherapy (PRP) in Type 2 Diabetes. JPMA. The Journal of the Pakistan Medical Association. 2024;74(11):2012-2013. doi:10.47391/jpma.24-89
Abstract
This brief communication describes the concept of physiofriendly pharmacotherapy for type 2 diabetes mellitus. Physio-friendly therapy is defined as that which restores metabolic, including glycaemic and weight homoeostasis, to near normal levels. Drugs such as glucagon like peptide 1 receptor agonists (GLP1RA), sodium glucose cotransporter- 2 inhibitors (SGLT2i), and alfa glucosidase inhibitors, along with metformin, work in a physio-friendly manner and may facilitate remission. Thus, they can also be termed as remission-facilitating drugs.
Keywords
- Diabetes
- relapse
- remission
- person centred care
- type 2 diabetes
